Neurosanatio s.r.o.
- Address
- lock Available on a paid plan
Neurosanatio s.r.o. - Neurological Research Center
Neurosanatio s.r.o. is a specialized clinical research facility dedicated to advancing therapeutic solutions for complex neurological conditions. The center focuses on innovative treatment approaches for patients who have exhausted conventional therapeutic options, with particular emphasis on chronic neurological disorders that significantly impact quality of life.
- Migraine prevention therapies and novel pharmaceutical interventions
- Treatment-resistant neurological conditions requiring advanced therapeutic strategies
- Dose-finding studies and efficacy evaluation of emerging neurological medications
The research team at Neurosanatio specializes in conducting rigorous clinical trials for patients with migraine who have not responded adequately to prior preventative treatments. Through systematic dose-finding studies and efficacy assessments, the center contributes valuable data to the development of next-generation neurological therapeutics, helping to expand treatment options for individuals living with chronic and debilitating neurological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neurosanatio s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of Lu AG09222 for Migraine Prevention in Adults with Episodic and Chronic Migraine | H. Lundbeck A/S | Phase II | Not Recruiting | Aug 2024 | Mar 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lu Ag09222 | 1 | Unknown | 2024-08-14 | 2024-08-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.